{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:55:07Z","timestamp":1792446907841,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2505300"],"award-info":[{"award-number":["2022YFC2505300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200896"],"award-info":[{"award-number":["82200896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04043-4","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T17:22:32Z","timestamp":1727284952000},"page":"334-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of cortisol on liver fat and metabolic health in adrenal incidentalomas and Cushing\u2019s syndrome"],"prefix":"10.1007","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4942-7139","authenticated-orcid":false,"given":"Peng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-0207","authenticated-orcid":false,"given":"Xiaomu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-0237","authenticated-orcid":false,"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"issue":"8","key":"4043_CR1","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G Marchesini","year":"2001","unstructured":"G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A.J. McCullough, S. Natale, G. Forlani, N. Melchionda, Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50(8), 1844\u20131850 (2001)","journal-title":"Diabetes"},{"key":"4043_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154770","volume":"119","author":"E Muzurovi\u0107","year":"2021","unstructured":"E. Muzurovi\u0107, D.P. Mikhailidis, C. Mantzoros, Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism 119, 154770 (2021)","journal-title":"Metabolism"},{"issue":"14","key":"4043_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"G. Targher, C.P. Day, E. Bonora, Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363(14), 1341\u20131350 (2010)","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"4043_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"S.A. Harrison, P. Bedossa, C.D. Guy, J.M. Schattenberg, R. Loomba, R. Taub, D. Labriola, S.E. Moussa, G.W. Neff, M.E. Rinella et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390(6), 497\u2013509 (2024)","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"4043_CR5","first-page":"748","volume":"35","author":"G Targher","year":"2012","unstructured":"G. Targher, A.P. Rossi, G.A. Zamboni, F. Fantin, A. Antonioli, F. Corzato, C. Bambace, R. Pozzi Mucelli, M. Zamboni, Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. J. Endocrinol. Invest. 35(8), 748\u2013753 (2012)","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"4043_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00125-022-05793-4","volume":"66","author":"J Ko","year":"2023","unstructured":"J. Ko, I.R. Sequeira, L. Skudder-Hill, J. Cho, S.D. Poppitt, M.S. Petrov, Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis. Diabetologia 66(1), 190\u2013200 (2023)","journal-title":"Diabetologia"},{"issue":"6","key":"4043_CR7","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1210\/clinem\/dgad766","volume":"109","author":"M Zhang","year":"2024","unstructured":"M. Zhang, Z. Shi, C. Wu, F. Yang, T. Su, X. Jing, J. Shi, H. Ren, L. Jiang, Y. Jiang et al. Cushing syndrome is associated with gut microbial dysbiosis and cortisol-degrading bacteria. J. Clin. Endocrinol. Metab. 109(6), 1474\u20131484 (2024)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4043_CR8","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1210\/clinem\/dgad560","volume":"109","author":"V Favero","year":"2024","unstructured":"V. Favero, C. Eller-Vainicher, V. Morelli, E. Cairoli, A.S. Salcuni, A. Scillitani, S. Corbetta, S.D. Casa, G. Muscogiuri, L. Persani et al. Increased risk of vertebral fractures in patients with mild autonomous cortisol secretion. J. Clin. Endocrinol. Metab. 109(2), e623\u2013e632 (2024)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4043_CR9","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1210\/clinem\/dgad665","volume":"109","author":"AX Chen","year":"2024","unstructured":"A.X. Chen, A. Radhakutty, S.M. Drake, A. Kiu, C.H. Thompson, M.G. Burt, Cardiovascular risk markers in adults with adrenal incidentaloma and mild autonomous cortisol secretion. J. Clin. Endocrinol. Metab. 109(3), e1020\u2013e1028 (2024)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4043_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11102-016-0726-1","volume":"19","author":"MK Auer","year":"2016","unstructured":"M.K. Auer, G.K. Stalla, M.R. Stieg, Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas. Pituitary 19(5), 461\u2013471 (2016)","journal-title":"Pituitary"},{"issue":"1","key":"4043_CR11","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-19-0893","volume":"182","author":"R Pasquali","year":"2020","unstructured":"R. Pasquali, F. Casanueva, M. Haluzik, L. van Hulsteijn, S. Ledoux, M.P. Monteiro, J. Salvador, F. Santini, H. Toplak, O.M. Dekkers, European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. Eur. J. Endocrinol. 182(1), G1\u2013G32 (2020)","journal-title":"Eur. J. Endocrinol."},{"issue":"21","key":"4043_CR12","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.3390\/ijms222111521","volume":"22","author":"V Favero","year":"2021","unstructured":"V. Favero, A. Cremaschi, A. Falchetti, A. Gaudio, L. Gennari, A. Scillitani, F. Vescini, V. Morelli, C. Aresta, I. Chiodini, Management and medical therapy of mild hypercortisolism. Int. J. Mol. Sci. 22(21), 11521 (2021)","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"4043_CR13","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"M. Fassnacht, S. Tsagarakis, M. Terzolo, A. Tabarin, A. Sahdev, J. Newell-Price, I. Pelsma, L. Marina, K. Lorenz, I. Bancos et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 189(1), G1\u2013G42 (2023)","journal-title":"Eur. J. Endocrinol."},{"key":"4043_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100780","volume":"36","author":"QM Anstee","year":"2024","unstructured":"Q.M. Anstee, T.L. Berentzen, L.M. Nitze, M. Jara, A.B. Jensen, M.S. Kj\u00e6r, K.K. Mangla, J.M. Tarp, K. Khunti, Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and\/or type 2 diabetes: a longitudinal cohort study. Lancet Reg. Health Eur. 36, 100780 (2024)","journal-title":"Lancet Reg. Health Eur."},{"key":"4043_CR15","doi-asserted-by":"crossref","unstructured":"American DAPP: 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care 47(1), S20\u2013S42 (2024)","DOI":"10.2337\/dc24-S002"},{"issue":"3","key":"4043_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3758\/BRM.40.3.879","volume":"40","author":"KJ Preacher","year":"2008","unstructured":"K.J. Preacher, A.F. Hayes, Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 40(3), 879\u2013891 (2008)","journal-title":"Behav. Res. Methods"},{"issue":"10","key":"4043_CR17","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1210\/jc.2003-030596","volume":"88","author":"J Westerbacka","year":"2003","unstructured":"J. Westerbacka, H. Yki-Jarvinen, S. Vehkavaara, A.M. Hakkinen, R. Andrew, D.J. Wake, J.R. Seckl, B.R. Walker, Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol\/cortisone metabolite ratios in men with fatty liver. J. Clin. Endocrinol. Metab. 88(10), 4924\u20134931 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1 Pt 1","key":"4043_CR18","first-page":"E119","volume":"264","author":"RE Goldstein","year":"1993","unstructured":"R.E. Goldstein, D.H. Wasserman, O.P. McGuinness, D.B. Lacy, A.D. Cherrington, N.N. Abumrad, Effects of chronic elevation in plasma cortisol on hepatic carbohydrate metabolism. Am. J. Physiol. 264(1 Pt 1), E119 (1993)","journal-title":"Am. J. Physiol."},{"key":"4043_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psyneuen.2018.12.237","volume":"103","author":"R Ortiz","year":"2019","unstructured":"R. Ortiz, B. Kluwe, J.B. Odei, J.B. Echouffo Tcheugui, M. Sims, R.R. Kalyani, A.G. Bertoni, S.H. Golden, J.J. Joseph, The association of morning serum cortisol with glucose metabolism and diabetes: the Jackson Heart Study. Psychoneuroendocrinology 103, 25\u201332 (2019)","journal-title":"Psychoneuroendocrinology"},{"issue":"4 Pt 1","key":"4043_CR20","first-page":"E595","volume":"268","author":"S Dinneen","year":"1995","unstructured":"S. Dinneen, A. Alzaid, J. Miles, R. Rizza, Effects of the normal nocturnal rise in cortisol on carbohydrate and fat metabolism in IDDM. Am. J. Physiol. 268(4 Pt 1), E595\u2013E603 (1995)","journal-title":"Am. J. Physiol."},{"issue":"10","key":"4043_CR21","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1111\/jcmm.13156","volume":"21","author":"ME Cornide Petronio","year":"2017","unstructured":"M.E. Cornide Petronio, E. Bujaldon, M. Mendes Braz, C.G. Avalos De Le\u00f3n, M.B. Jim\u00e9nez Castro, A.I. \u00c1lvarez Mercado, J. Gracia Sancho, J. Rod\u00e9s, C. Peralta, The impact of cortisol in steatotic and non-steatotic liver surgery. J. Cell Mol. Med. 21(10), 2344\u20132358 (2017)","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"4043_CR22","doi-asserted-by":"publisher","first-page":"M133","DOI":"10.1530\/EJE-15-0354","volume":"173","author":"F Ferra\u00f9","year":"2015","unstructured":"F. Ferra\u00f9, M. Korbonits, Metabolic comorbidities in Cushing\u2019s syndrome*. Eur. J. Endocrinol. 173(4), M133\u2013M157 (2015)","journal-title":"Eur. J. Endocrinol."},{"key":"4043_CR23","doi-asserted-by":"crossref","unstructured":"X. Sun, M. Feng, L. Lu, Z. Zhao, X. Bao, K. Deng, Y. Yao, H. Zhu, R. Wang. Lipid abnormalities in patients with Cushing\u2019s disease and its relationship with impaired glucose metabolism. Front. Endocrinol. 11, 600323 (2021)","DOI":"10.3389\/fendo.2020.600323"},{"issue":"2","key":"4043_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13679-024-00556-1","volume":"13","author":"SA Polyzos","year":"2024","unstructured":"S.A. Polyzos, G. Targher, Role of glucocorticoids in metabolic dysfunction-associated steatotic liver disease. Curr. Obes. Rep. 13(2), 242\u2013255 (2024)","journal-title":"Curr. Obes. Rep."},{"issue":"7","key":"4043_CR25","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.metabol.2005.01.030","volume":"54","author":"Y Liang","year":"2005","unstructured":"Y. Liang, M.C. Osborne, B.P. Monia, S. Bhanot, L.M. Watts, P. She, S.O. DeCarlo, X. Chen, K. Demarest, Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice. Metabolism 54(7), 848\u2013855 (2005)","journal-title":"Metabolism"},{"issue":"2","key":"4043_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/ijms22020623","volume":"22","author":"C Beaupere","year":"2021","unstructured":"C. Beaupere, A. Liboz, B. F\u00e8ve, B. Blondeau, G. Guillemain, Molecular mechanisms of glucocorticoid-induced insulin resistance. Int. J. Mol. Sci. 22(2), 623 (2021)","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"4043_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1210\/endo-81-3-486","volume":"81","author":"B Friedmann","year":"1967","unstructured":"B. Friedmann, J.E.H. Goodman, S. Weinhouse, Effects of glucose feeding, cortisol, and insulin on liver glycogen synthesis in the rat. Endocrinology 81(3), 486 (1967)","journal-title":"Endocrinology"},{"issue":"5","key":"4043_CR28","first-page":"1273","volume":"14","author":"RM de Guia","year":"2020","unstructured":"R.M. de Guia, Stress, glucocorticoid signaling pathway, and metabolic disorders. Diab. Metab. Syndr. Clin. Res. Rev. 14(5), 1273\u20131280 (2020)","journal-title":"Diab. Metab. Syndr. Clin. Res. Rev."},{"issue":"8","key":"4043_CR29","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s00125-006-0295-3","volume":"49","author":"MO Weickert","year":"2006","unstructured":"M.O. Weickert, A.F.H. Pfeiffer, Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49(8), 1732\u20131741 (2006)","journal-title":"Diabetologia"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04043-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04043-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04043-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T07:53:28Z","timestamp":1737014008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04043-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["4043"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04043-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4789599\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Written, informed consent was obtained from all of the participants, and the study was approved by the ethics committee of Zhongshan Hospital, Fudan University, China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}